UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
Commission File Number:
|
||
(State or other jurisdiction of incorporation) |
|
(IRS Employer Identification No.) |
(Address of principal executive offices, including zip code)
(
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of Each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition
On October 19, 2022, Stepan Company (“Stepan”) issued a press release providing its financial results for the quarter ended September 30, 2022. A copy of the press release is attached as Exhibit 99.1 hereto and incorporated herein by reference.
Item 8.01. Other Events
In addition, on October 19, 2022, Stepan issued a press release announcing that its Board of Directors declared a quarterly cash dividend on its common stock of $0.365 per share. The dividend will be paid on December 15, 2022, to common stockholders of record on November 30, 2022. A copy of the press release is attached as Exhibit 99.2 hereto and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
Exhibit Number: 99.1
Description: Press Release of Stepan Company dated October 19, 2022
Exhibit Number: 99.2
Description: Press Release of Stepan Company dated October 19, 2022
Exhibit Number: 104
Description: Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
STEPAN COMPANY |
Date: October 19, 2022 |
|
|
|
By: |
|
/s/ David G. Kabbes |
|
|
|
|
|
|
David G. Kabbes |
|
|
|
|
|
|
Vice President, General Counsel and Secretary |
Exhibit 99.1
Stepan Reports Record Third Quarter Results and Record Nine Month Earnings
Northbrook, Illinois, October 19, 2022 -- Stepan Company (NYSE: SCL) today reported:
Third Quarter Highlights
YTD Highlights
1
* Adjusted net income is a non-GAAP measure which excludes deferred compensation income/expense, cash-settled stock appreciation rights (SARs) income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and earnings per diluted share.
“The Company had strong performance for the first nine months of 2022 and delivered record results, despite ongoing supply chain challenges. Reported net income was up 13% versus the first nine months of 2021 while adjusted net income was up 16%," said Scott Behrens, President and Chief Executive Officer. “For the quarter, Surfactant operating income was up 13% largely due to improved product and customer mix. This improvement was driven by growth in our Functional Products business as a result of elevated crop and energy prices, which offset an 8% decline in sales volume primarily within our Consumer Products business. Our Polymer income was up 61% due to margin recovery and improved mix that was partially offset by a 10% decline in sales volume. Our Specialty Product results improved significantly due to margin improvement and favorable customer mix."
Financial Summary
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||||||||||
($ in thousands, except per share data) |
|
2022 |
|
|
2021 |
|
|
% |
|
|
2022 |
|
|
2021 |
|
|
% |
|
||||||
Net Sales |
|
$ |
719,185 |
|
|
$ |
602,688 |
|
|
|
19 |
% |
|
$ |
2,146,094 |
|
|
$ |
1,735,939 |
|
|
|
24 |
% |
Operating Income |
|
$ |
54,659 |
|
|
$ |
40,213 |
|
|
|
36 |
% |
|
$ |
195,645 |
|
|
$ |
150,784 |
|
|
|
30 |
% |
Net Income Attributable to Stepan Company ** |
|
$ |
39,384 |
|
|
$ |
36,920 |
|
|
|
7 |
% |
|
$ |
136,319 |
|
|
$ |
120,809 |
|
|
|
13 |
% |
Earnings per Diluted Share |
|
$ |
1.71 |
|
|
$ |
1.59 |
|
|
|
8 |
% |
|
$ |
5.90 |
|
|
$ |
5.19 |
|
|
|
14 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Adjusted Net Income * |
|
$ |
46,281 |
|
|
$ |
36,417 |
|
|
|
27 |
% |
|
$ |
140,017 |
|
|
$ |
121,005 |
|
|
|
16 |
% |
Adjusted Earnings per Diluted Share * |
|
$ |
2.01 |
|
|
$ |
1.57 |
|
|
|
28 |
% |
|
$ |
6.06 |
|
|
$ |
5.20 |
|
|
|
17 |
% |
Summary of Third Quarter Adjusted Net Income Items
Adjusted net income excludes non-operational deferred compensation income/expense, cash-settled SARs income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.
2
Percentage Change in Net Sales
Net sales in the third quarter of 2022 increased 19% year-over-year primarily due to higher selling prices that were mainly attributable to the pass-through of higher raw material and logistics costs and improved product and customer mix. These higher average selling prices were partially offset by an 8% decrease in global sales volume and the unfavorable impact of foreign currency translation.
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||
Volume |
|
|
(8 |
)% |
|
|
(3 |
)% |
Selling Price & Mix |
|
|
33 |
% |
|
|
31 |
% |
Foreign Translation |
|
|
(6 |
)% |
|
|
(4 |
)% |
Total |
|
|
19 |
% |
|
|
24 |
% |
Reported Segment Results
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||||||||||
($ in thousands) |
|
2022 |
|
|
2021 |
|
|
% |
|
|
2022 |
|
|
2021 |
|
|
% |
|
||||||
Net Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Surfactants |
|
$ |
474,861 |
|
|
$ |
387,734 |
|
|
|
22 |
% |
|
$ |
1,428,211 |
|
|
$ |
1,142,672 |
|
|
|
25 |
% |
Polymers |
|
$ |
214,807 |
|
|
$ |
198,841 |
|
|
|
8 |
% |
|
$ |
640,771 |
|
|
$ |
539,764 |
|
|
|
19 |
% |
Specialty Products |
|
$ |
29,517 |
|
|
$ |
16,113 |
|
|
|
83 |
% |
|
$ |
77,112 |
|
|
$ |
53,503 |
|
|
|
44 |
% |
Total Net Sales |
|
$ |
719,185 |
|
|
$ |
602,688 |
|
|
|
19 |
% |
|
$ |
2,146,094 |
|
|
$ |
1,735,939 |
|
|
|
24 |
% |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||||||||||
($ in thousands, all amounts pre-tax) |
|
2022 |
|
|
2021 |
|
|
% |
|
|
2022 |
|
|
2021 |
|
|
% |
|
||||||
Operating Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Surfactants |
|
$ |
38,976 |
|
|
$ |
34,452 |
|
|
|
13 |
% |
|
$ |
140,994 |
|
|
$ |
133,558 |
|
|
|
6 |
% |
Polymers |
|
$ |
31,864 |
|
|
$ |
19,753 |
|
|
|
61 |
% |
|
$ |
79,905 |
|
|
$ |
60,729 |
|
|
|
32 |
% |
Specialty Products |
|
$ |
9,685 |
|
|
$ |
2,442 |
|
|
|
297 |
% |
|
$ |
23,246 |
|
|
$ |
12,052 |
|
|
|
93 |
% |
Total Segment Operating Income |
|
$ |
80,525 |
|
|
$ |
56,647 |
|
|
|
42 |
% |
|
$ |
244,145 |
|
|
$ |
206,339 |
|
|
|
18 |
% |
Corporate Expenses |
|
$ |
(25,866 |
) |
|
$ |
(16,434 |
) |
|
|
57 |
% |
|
$ |
(48,500 |
) |
|
$ |
(55,555 |
) |
|
|
(13 |
)% |
Consolidated Operating Income |
|
$ |
54,659 |
|
|
$ |
40,213 |
|
|
|
36 |
% |
|
$ |
195,645 |
|
|
$ |
150,784 |
|
|
|
30 |
% |
Total segment operating income for the third quarter of 2022 increased $23.9 million, or 42%, versus the prior year quarter. Total segment operating income for the first nine months of 2022 increased $37.8 million, or 18%, versus the prior year.
3
Corporate Expenses
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||||||||||
($ in thousands) |
|
2022 |
|
|
2021 |
|
|
% |
|
|
2022 |
|
|
2021 |
|
|
% |
|
||||||
Total Corporate Expenses |
|
$ |
25,866 |
|
|
$ |
16,434 |
|
|
|
57 |
% |
|
$ |
48,500 |
|
|
$ |
55,555 |
|
|
|
(13 |
)% |
Less: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Deferred Compensation Expense (Income) |
|
$ |
(2,131 |
) |
|
$ |
(1,504 |
) |
|
|
42 |
% |
|
$ |
(13,038 |
) |
|
$ |
2,148 |
|
|
NM |
|
|
Business Restructuring Expense |
|
$ |
92 |
|
|
$ |
72 |
|
|
|
28 |
% |
|
$ |
225 |
|
|
$ |
267 |
|
|
|
(16 |
)% |
Environmental Remediation Expense |
|
$ |
10,372 |
|
|
$ |
946 |
|
|
NM |
|
|
$ |
11,002 |
|
|
$ |
946 |
|
|
NM |
|
||
Adjusted Corporate Expenses |
|
$ |
17,533 |
|
|
$ |
16,920 |
|
|
|
4 |
% |
|
$ |
50,311 |
|
|
$ |
52,194 |
|
|
|
(4 |
)% |
* See Table III for a discussion of deferred compensation plan accounting. |
Income Taxes and Net Interest
The Company’s effective tax rate was 24.0% for the first nine months of 2022 versus 19.6% for the first nine months of 2021. This year-over-year increase was primarily due to a non-recurring favorable tax benefit recognized in the third quarter of 2021 related to the merger of the Company's three Brazilian entities into a single entity.
Shareholder Return
4
The Company paid $7.5 million of dividends to shareholders and repurchased $5.3 million of Company stock in the third quarter of 2022. During the first nine months of 2022 the Company paid $22.5 million of dividends and repurchased $22.3 million of Company stock. The Company has $127.7 million remaining under the share repurchase program authorized by its Board of Directors. With the cash dividend increase in the fourth quarter of 2022, the Company has increased its dividend on the Company’s common stock for the 55th consecutive year.
Selected Balance Sheet Information
The Company’s total debt increased by $38.9 million and cash decreased by $28.9 million versus June 30, 2022. The increase in debt primarily reflects a $100.0 million borrowing against the previously disclosed delayed draw term loan facility that was partially offset by scheduled debt and revolving credit facility repayments. The decrease in cash primarily reflects higher working capital requirements, capital expenditures and the Company's previously announced third quarter 2022 acquisition of the PerformanX Specialty Chemicals surfactants business. The Company’s net debt level increased $67.8 million versus June 30, 2022 and the net debt ratio increased from 23% to 26% in the quarter (Net Debt and Net Debt Ratio are non-GAAP measures).
($ in millions) |
|
9/30/22 |
|
|
6/30/22 |
|
|
3/31/22 |
|
|
12/31/21 |
|
||||
Net Debt |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total Debt |
|
$ |
564.9 |
|
|
$ |
526.0 |
|
|
$ |
537.1 |
|
|
$ |
363.6 |
|
Cash |
|
|
165.7 |
|
|
|
194.6 |
|
|
|
236.0 |
|
|
|
159.2 |
|
Net Debt |
|
$ |
399.2 |
|
|
$ |
331.4 |
|
|
$ |
301.1 |
|
|
$ |
204.4 |
|
Equity |
|
|
1,130.2 |
|
|
|
1,125.7 |
|
|
|
1,116.7 |
|
|
|
1,074.2 |
|
Net Debt + Equity |
|
$ |
1,529.4 |
|
|
$ |
1,457.1 |
|
|
$ |
1,417.8 |
|
|
$ |
1,278.6 |
|
Net Debt / (Net Debt + Equity) |
|
|
26 |
% |
|
|
23 |
% |
|
|
21 |
% |
|
|
16 |
% |
The major working capital components were:
($ in millions) |
|
9/30/22 |
|
|
6/30/22 |
|
|
3/31/22 |
|
|
12/31/22 |
|
||||
Net Receivables |
|
$ |
476.2 |
|
|
$ |
518.8 |
|
|
$ |
504.5 |
|
|
$ |
419.5 |
|
Inventories |
|
|
397.6 |
|
|
|
340.7 |
|
|
|
308.4 |
|
|
|
305.5 |
|
Accounts Payable |
|
|
(350.1 |
) |
|
|
(366.2 |
) |
|
|
(350.8 |
) |
|
|
(323.4 |
) |
|
|
$ |
523.7 |
|
|
$ |
493.3 |
|
|
$ |
462.1 |
|
|
$ |
401.6 |
|
Capital spending was $75.9 million during the quarter and $205.3 million during the first nine months of 2022. This compares to $44.7 million and $119.5 million, respectively, in the prior year. The year-over-year increase is primarily due to increased expenditures in the U.S. for the advancement of the Company's new alkoxylation facility in Pasadena, TX, which is expected to provide flexible capacity of 75,000 metric tons per year, and new capability and capacity to produce ether sulfates that will meet upcoming regulatory limits on 1,4 dioxane. For the full year, capital expenditures are expected to be in the range of $330 million to $350 million.
Outlook
“The Company delivered record third quarter and nine-month results and we expect to deliver record full year earnings again in 2022. For the fourth quarter we anticipate approximately $8 million of incremental expense related to planned maintenance activity in our North American Phthalic Anhydride plant and low 1,4 dioxane transition costs,” said Scott Behrens, President and Chief Executive Officer. “From a segment perspective, we believe that Surfactants, Polymers and Specialty Products should all deliver full year earnings growth versus prior year. Surfactant volumes within the Functional Products and Industrial Cleaning end markets are expected to show full year growth over
5
2021. Despite short-term volatility and challenges, we believe that the long-term outlook for Rigid Polyols will remain attractive as energy conservation efforts and more stringent building codes are expected to continue. Looking forward to the next few quarters, we believe the Company will be challenged by slowing global economic growth, weakening consumer and construction demand, continued inflationary pressures and a stronger U.S. dollar. Despite this projected macro environment, we remain committed to executing our long-term growth strategy.”
Conference Call
Stepan Company will host a conference call to discuss the third quarter results at 10:00 a.m. ET (9:00 a.m. CT) on October 19, 2022. The call can be accessed by phone and webcast. Telephone access will be available by dialing +1 (800) 769-9015, and the webcast can be accessed through the Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.
Supporting Slides
Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.
Corporate Profile
Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.
Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.
The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com
More information about Stepan’s sustainability program can be found on the Sustainability page at www.stepan.com
Contact: Luis E. Rojo 847-446-7500
Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company’s plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “should,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their
6
knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.
There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to the impact of the COVID-19 pandemic; accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.
These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
7
Table I
STEPAN COMPANY
For the Three and Nine Months Ended September 30, 2022 and 2021
(Unaudited – 000’s Omitted)
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Net Sales |
|
$ |
719,185 |
|
|
$ |
602,688 |
|
|
$ |
2,146,094 |
|
|
$ |
1,735,939 |
|
Cost of Sales |
|
|
600,709 |
|
|
|
510,792 |
|
|
|
1,786,785 |
|
|
|
1,423,382 |
|
Gross Profit |
|
|
118,476 |
|
|
|
91,896 |
|
|
|
359,309 |
|
|
|
312,557 |
|
Operating Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Selling |
|
|
15,079 |
|
|
|
14,786 |
|
|
|
45,908 |
|
|
|
44,280 |
|
Administrative |
|
|
33,848 |
|
|
|
22,828 |
|
|
|
79,499 |
|
|
|
69,440 |
|
Research, Development and Technical Services |
|
|
16,929 |
|
|
|
15,501 |
|
|
|
50,092 |
|
|
|
45,638 |
|
Deferred Compensation Expense (Income) |
|
|
(2,131 |
) |
|
|
(1,504 |
) |
|
|
(13,038 |
) |
|
|
2,148 |
|
|
|
|
63,725 |
|
|
|
51,611 |
|
|
|
162,461 |
|
|
|
161,506 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Goodwill Impairment |
|
|
- |
|
|
|
- |
|
|
|
978 |
|
|
|
- |
|
Business Restructuring |
|
|
92 |
|
|
|
72 |
|
|
|
225 |
|
|
|
267 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Operating Income |
|
|
54,659 |
|
|
|
40,213 |
|
|
|
195,645 |
|
|
|
150,784 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Other Income (Expense): |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Interest, Net |
|
|
(2,221 |
) |
|
|
(1,599 |
) |
|
|
(7,254 |
) |
|
|
(4,690 |
) |
Other, Net |
|
|
(1,980 |
) |
|
|
702 |
|
|
|
(8,999 |
) |
|
|
4,206 |
|
|
|
|
(4,201 |
) |
|
|
(897 |
) |
|
|
(16,253 |
) |
|
|
(484 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Income Before Income Taxes |
|
|
50,458 |
|
|
|
39,316 |
|
|
|
179,392 |
|
|
|
150,300 |
|
Provision for Income Taxes |
|
|
11,074 |
|
|
|
2,393 |
|
|
|
43,073 |
|
|
|
29,463 |
|
Net Income |
|
|
39,384 |
|
|
|
36,923 |
|
|
|
136,319 |
|
|
|
120,837 |
|
Net Income Attributable to Noncontrolling Interests |
|
|
|
|
|
(3 |
) |
|
|
|
|
|
(28 |
) |
||
Net Income Attributable to Stepan Company |
|
$ |
39,384 |
|
|
$ |
36,920 |
|
|
$ |
136,319 |
|
|
$ |
120,809 |
|
Net Income Per Common Share Attributable to Stepan Company |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
$ |
1.73 |
|
|
$ |
1.61 |
|
|
$ |
5.98 |
|
|
$ |
5.27 |
|
Diluted |
|
$ |
1.71 |
|
|
$ |
1.59 |
|
|
$ |
5.90 |
|
|
$ |
5.19 |
|
Shares Used to Compute Net Income Per Common |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
|
22,753 |
|
|
|
22,898 |
|
|
|
22,813 |
|
|
|
22,941 |
|
Diluted |
|
|
23,034 |
|
|
|
23,219 |
|
|
|
23,089 |
|
|
|
23,299 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
8
Table II
Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share *
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
|
2022 |
|
|
EPS |
|
|
2021 |
|
|
EPS |
|
|
2022 |
|
|
EPS |
|
|
2021 |
|
|
EPS |
|
||||||||
Net Income Reported |
|
$ |
39,384 |
|
|
$ |
1.71 |
|
|
$ |
36,920 |
|
|
$ |
1.59 |
|
|
$ |
136,319 |
|
|
$ |
5.90 |
|
|
$ |
120,809 |
|
|
$ |
5.19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Deferred Compensation (Income) Expense |
|
$ |
(938 |
) |
|
$ |
(0.04 |
) |
|
$ |
(1,135 |
) |
|
$ |
(0.05 |
) |
|
$ |
(4,369 |
) |
|
$ |
(0.19 |
) |
|
$ |
(685 |
) |
|
$ |
(0.03 |
) |
Business Restructuring Expense |
|
$ |
69 |
|
|
$ |
- |
|
|
$ |
54 |
|
|
$ |
- |
|
|
$ |
169 |
|
|
$ |
0.01 |
|
|
$ |
200 |
|
|
$ |
0.01 |
|
Cash-Settled SARs (Income) Expense |
|
$ |
(117 |
) |
|
$ |
- |
|
|
$ |
(141 |
) |
|
$ |
- |
|
|
$ |
(464 |
) |
|
$ |
(0.02 |
) |
|
$ |
(38 |
) |
|
$ |
- |
|
Environmental Remediation Expense |
|
$ |
7,883 |
|
|
$ |
0.34 |
|
|
$ |
719 |
|
|
$ |
0.03 |
|
|
$ |
8,362 |
|
|
$ |
0.36 |
|
|
$ |
719 |
|
|
$ |
0.03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Adjusted Net Income |
|
$ |
46,281 |
|
|
$ |
2.01 |
|
|
$ |
36,417 |
|
|
$ |
1.57 |
|
|
$ |
140,017 |
|
|
$ |
6.06 |
|
|
$ |
121,005 |
|
|
$ |
5.20 |
|
* All amounts in this table are presented after-tax
The Company believes that certain measures that are not in accordance with generally accepted accounting principles (GAAP), when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company’s operating performance and provide better clarity on the impact of non-operational items. Internally, the Company uses this non-GAAP information as an indicator of business performance and evaluates management’s effectiveness with specific reference to these indicators. These measures should be considered in addition to, neither a substitute for, nor superior to, measures of financial performance prepared in accordance with GAAP.
Reconciliation of Pre-Tax to After-Tax Adjustments
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
|
2022 |
|
|
EPS |
|
|
2021 |
|
|
EPS |
|
|
2022 |
|
|
EPS |
|
|
2021 |
|
|
EPS |
|
||||||||
Pre-Tax Adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Deferred Compensation (Income) Expense |
|
$ |
(1,234 |
) |
|
|
|
|
$ |
(1,494 |
) |
|
|
|
|
$ |
(5,748 |
) |
|
|
|
|
$ |
(901 |
) |
|
|
|
||||
Business Restructuring Expense |
|
$ |
92 |
|
|
|
|
|
$ |
72 |
|
|
|
|
|
$ |
225 |
|
|
|
|
|
$ |
267 |
|
|
|
|
||||
Cash-Settled SARs (Income) Expense |
|
$ |
(154 |
) |
|
|
|
|
$ |
(186 |
) |
|
|
|
|
$ |
(609 |
) |
|
|
|
|
$ |
(50 |
) |
|
|
|
||||
Environmental Remediation Expense |
|
$ |
10,372 |
|
|
|
|
|
$ |
946 |
|
|
|
|
|
$ |
11,002 |
|
|
|
|
|
$ |
946 |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Total Pre-Tax Adjustments |
|
$ |
9,076 |
|
|
|
|
|
$ |
(662 |
) |
|
|
|
|
$ |
4,870 |
|
|
|
|
|
$ |
262 |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Cumulative Tax Effect on Adjustments |
|
$ |
(2,179 |
) |
|
|
|
|
$ |
159 |
|
|
|
|
|
$ |
(1,172 |
) |
|
|
|
|
$ |
(66 |
) |
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
After-Tax Adjustments |
|
$ |
6,897 |
|
|
$ |
0.30 |
|
|
$ |
(503 |
) |
|
$ |
(0.02 |
) |
|
$ |
3,698 |
|
|
$ |
0.16 |
|
|
$ |
196 |
|
|
$ |
0.01 |
|
9
Table III
Deferred Compensation Plans
The full effect of deferred compensation plans on quarterly pre-tax income was $1.2 million of income versus $1.5 million of income in the prior year. The year-to-date impact was $5.7 million of income versus $0.9 million of income in the prior year. The accounting for deferred compensation plans results in operating income when the price of Stepan Company common stock or mutual funds held in the plans fall and expense when they rise. The Company also recognizes the change in value of mutual funds as investment income or loss. The quarter end market prices of Company common stock were as follows:
|
|
2022 |
|
|
2021 |
|
||||||||||||||||||||||||
|
|
12/31 |
|
9/30 |
|
|
6/30 |
|
|
3/31 |
|
|
12/31 |
|
|
9/30 |
|
|
6/30 |
|
|
3/31 |
|
|||||||
Stepan Company |
|
N/A |
|
$ |
93.67 |
|
|
$ |
101.35 |
|
|
$ |
98.81 |
|
|
$ |
124.29 |
|
|
$ |
112.94 |
|
|
$ |
120.27 |
|
|
$ |
127.11 |
|
The deferred compensation income statement impact is summarized below:
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
($ in thousands) |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Deferred Compensation |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Operating Income (Expense) |
|
$ |
2,131 |
|
|
$ |
1,504 |
|
|
$ |
13,038 |
|
|
$ |
(2,148 |
) |
Other, net – Mutual Fund Gain (Loss) |
|
|
(897 |
) |
|
|
(10 |
) |
|
|
(7,290 |
) |
|
|
3,049 |
|
Total Pre-Tax |
|
$ |
1,234 |
|
|
$ |
1,494 |
|
|
$ |
5,748 |
|
|
$ |
901 |
|
Total After-Tax |
|
$ |
938 |
|
|
$ |
1,135 |
|
|
$ |
4,368 |
|
|
$ |
685 |
|
10
Table IV
Effects of Foreign Currency Translation
The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign currency exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). Below is a table that presents the impact that foreign currency translation had on the changes in consolidated net sales and various income line items for the three and nine month periods ending September 30, 2022 as compared to 2021:
($ in millions) |
|
Three Months Ended |
|
|
Increase |
|
|
Change |
|
|
Nine Months Ended |
|
|
Increase |
|
|
Change |
|
||||||||||||||
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
||||||||
Net Sales |
|
$ |
719.2 |
|
|
$ |
602.7 |
|
|
$ |
116.5 |
|
|
$ |
(35.7 |
) |
|
$ |
2,146.1 |
|
|
$ |
1,735.9 |
|
|
$ |
410.2 |
|
|
$ |
(72.9 |
) |
Gross Profit |
|
|
118.5 |
|
|
|
91.9 |
|
|
|
26.6 |
|
|
|
(4.5 |
) |
|
|
359.3 |
|
|
|
312.6 |
|
|
|
46.7 |
|
|
|
(9.7 |
) |
Operating Income |
|
|
54.7 |
|
|
|
40.2 |
|
|
|
14.5 |
|
|
|
(3.1 |
) |
|
|
195.6 |
|
|
|
150.8 |
|
|
|
44.8 |
|
|
|
(6.7 |
) |
Pretax Income |
|
|
50.5 |
|
|
|
39.3 |
|
|
|
11.2 |
|
|
|
(3.1 |
) |
|
|
179.4 |
|
|
|
150.3 |
|
|
|
29.1 |
|
|
|
(6.8 |
) |
11
Table V
Stepan Company
Consolidated Balance Sheets
September 30, 2022 and December 31, 2021
|
|
September 30, 2022 |
|
|
December 31, 2021 |
|
||
ASSETS |
|
|
|
|
|
|
||
Current Assets |
|
$ |
1,072,747 |
|
|
$ |
913,368 |
|
Property, Plant & Equipment, Net |
|
|
977,600 |
|
|
|
850,604 |
|
Other Assets |
|
|
286,423 |
|
|
|
301,640 |
|
Total Assets |
|
$ |
2,336,770 |
|
|
$ |
2,065,612 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
||
Current Liabilities |
|
$ |
603,245 |
|
|
$ |
500,476 |
|
Deferred Income Taxes |
|
|
11,111 |
|
|
|
12,491 |
|
Long-term Debt |
|
|
466,766 |
|
|
|
322,862 |
|
Other Non-current Liabilities |
|
|
125,409 |
|
|
|
155,590 |
|
Total Stepan Company Stockholders’ Equity |
|
|
1,130,239 |
|
|
|
1,074,193 |
|
Noncontrolling Interest |
|
|
- |
|
|
|
- |
|
Total Liabilities and Stockholders’ Equity |
|
$ |
2,336,770 |
|
|
$ |
2,065,612 |
|
12
Exhibit 99.2
Stepan Increases Quarterly Cash Dividend,
Marking the 55th Consecutive Year of Increases
Northbrook, Illinois, October 19, 2022 -- Stepan Company (NYSE:SCL) today reported:
On October 18, 2022, the Board of Directors of Stepan Company approved an increase of $0.030 per share, or 9.0%, on its quarterly cash dividend on its common stock. The dividend of $0.365 per share is payable on December 15, 2022, to common stockholders of record on November 30, 2022. The increase marks the 55th consecutive year in which the quarterly dividend rate on the Company’s common stock has increased.
Corporate Profile
Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection products and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.
Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.
The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com.
More information about Stepan’s sustainability program can be found on the Sustainability page at www.stepan.com.
Contact: Luis E. Rojo 847-446-7500
Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company’s plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “should,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar
expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.
There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to the impact of the COVID-19 pandemic; accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.
These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.